These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29984382)

  • 1. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
    Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
    J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
    Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous rectal adenocarcinoma can be associated to tumor downstaging after preoperative chemoradiotherapy.
    Grillo-Ruggieri F; Mantello G; Berardi R; Cardinali M; Fenu F; Iovini G; Montisci M; Fabbietti L; Marmorale C; Guerrieri M; Saba V; Bearzi I; Mattioli R; Bonsignori M; Cascinu S
    Dis Colon Rectum; 2007 Oct; 50(10):1594-603. PubMed ID: 17846841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemotherapy Improves Survival Following Resection of Locally Advanced Rectal Cancer with Pathologic Complete Response.
    Turner MC; Keenan JE; Rushing CN; Gulack BC; Nussbaum DP; Benrashid E; Hyslop T; Strickler JH; Mantyh CR; Migaly J
    J Gastrointest Surg; 2019 Aug; 23(8):1614-1622. PubMed ID: 30635829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer.
    Li Y; Pan C; Gao Y; Zhang L; Ji D; Cui X; Zhang X; Cai Y; Zhang Y; Yao Y; Wang L; Leng J; Zhan T; Wu D; Gao Z; Sun YS; Li Z; Luo H; Wu A
    JAMA Surg; 2024 May; 159(5):529-537. PubMed ID: 38381429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
    Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
    AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.
    Chang GJ; You YN; Park IJ; Kaur H; Hu CY; Rodriguez-Bigas MA; Skibber JM; Ernst RD
    Dis Colon Rectum; 2012 Apr; 55(4):371-7. PubMed ID: 22426259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRAS mutation status and clinical outcome of preoperative chemoradiation with cetuximab in locally advanced rectal cancer: a pooled analysis of 2 phase II trials.
    Kim SY; Shim EK; Yeo HY; Baek JY; Hong YS; Kim DY; Kim TW; Kim JH; Im SA; Jung KH; Chang HJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):201-7. PubMed ID: 22672749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of pathologic complete response for locally advanced rectal cancer.
    Cloos AJ; Schissel M; Batra R; Donahue SR; Wenos CD; Kumar T; Leinicke JA; Thompson JS; Langenfeld SJ
    Am J Surg; 2023 Dec; 226(6):873-877. PubMed ID: 37460372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.
    John AO; Singh A; Bala D; Joel A; Georgy JT; Jesudasan MR; Mittal R; Ram TS; Reddy JR; Murthy A; Chandramohan A; Eapen A; Masih D; Ramnath N; Dobrosotskaya I; Yadav B; Chacko RT
    J Gastrointest Cancer; 2024 Mar; 55(1):307-317. PubMed ID: 37479897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study.
    Kim SY; Hong YS; Kim DY; Kim TW; Kim JH; Im SA; Lee KS; Yun T; Jeong SY; Choi HS; Lim SB; Chang HJ; Jung KH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):677-83. PubMed ID: 20888703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.